Submitted by Anonymous (not verified) on 16 July 2026 - 14:08
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Revision: 37, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Revision: 37, Status: Authorised